Cargando…
First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults
CONTEXT: Prenatal dexamethasone (DEX) treatment is sometimes used in pregnancies at risk for congenital adrenal hyperplasia (CAH) to prevent virilization in female fetuses with CAH. In boys and in fetuses not having CAH, there is no benefit of early DEX treatment and the risks of this therapy must b...
Autores principales: | van’t Westeinde, Annelies, Zimmermann, Marius, Messina, Valeria, Karlsson, Leif, Padilla, Nelly, Lajic, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510958/ https://www.ncbi.nlm.nih.gov/pubmed/32869847 http://dx.doi.org/10.1210/clinem/dgaa611 |
Ejemplares similares
-
First Trimester Dexamethasone Treatment Is Not Associated With Alteration in Resting-state Connectivity at Adolescent or Adult Age
por: Messina, Valeria, et al.
Publicado: (2022) -
First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age
por: van’t Westeinde, Annelies, et al.
Publicado: (2020) -
Changes in resting-state functional connectivity in patients with congenital adrenal hyperplasia
por: Messina, Valeria, et al.
Publicado: (2022) -
Brain structure in autoimmune Addison’s disease
por: van’t Westeinde, Annelies, et al.
Publicado: (2022) -
An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
por: van’t Westeinde, Annelies, et al.
Publicado: (2023)